Collectively, these data indicate that GLP-1 analogues might be useful therapeutic means to improve glycaemic control by reducing visceral adipose tissue volume in South Asian type 2 diabetes patients. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.